2024-04-012025-03-302025-03-30false13261325THE KLINIK AESTHETIC LTD2025-08-0196020falseiso4217:GBPxbrli:pure132613252024-03-31132613252025-03-30132613252024-04-012025-03-30132613252023-03-31132613252024-03-31132613252023-04-012024-03-3113261325bus:SmallEntities2024-04-012025-03-3013261325bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3013261325bus:FullAccounts2024-04-012025-03-3013261325bus:PrivateLimitedCompanyLtd2024-04-012025-03-3013261325core:WithinOneYear2025-03-3013261325core:AfterOneYear2025-03-3013261325core:WithinOneYear2024-03-3113261325core:AfterOneYear2024-03-3113261325core:ShareCapital2025-03-3013261325core:SharePremium2025-03-3013261325core:RevaluationReserve2025-03-3013261325core:OtherReservesSubtotal2025-03-3013261325core:RetainedEarningsAccumulatedLosses2025-03-3013261325core:ShareCapital2024-03-3113261325core:SharePremium2024-03-3113261325core:RevaluationReserve2024-03-3113261325core:OtherReservesSubtotal2024-03-3113261325core:RetainedEarningsAccumulatedLosses2024-03-3113261325core:LandBuildings2025-03-3013261325core:PlantMachinery2025-03-3013261325core:Vehicles2025-03-3013261325core:FurnitureFittings2025-03-3013261325core:OfficeEquipment2025-03-3013261325core:NetGoodwill2025-03-3013261325core:IntangibleAssetsOtherThanGoodwill2025-03-3013261325core:ListedExchangeTraded2025-03-3013261325core:UnlistedNon-exchangeTraded2025-03-3013261325core:LandBuildings2024-03-3113261325core:PlantMachinery2024-03-3113261325core:Vehicles2024-03-3113261325core:FurnitureFittings2024-03-3113261325core:OfficeEquipment2024-03-3113261325core:NetGoodwill2024-03-3113261325core:IntangibleAssetsOtherThanGoodwill2024-03-3113261325core:ListedExchangeTraded2024-03-3113261325core:UnlistedNon-exchangeTraded2024-03-3113261325core:LandBuildings2024-04-012025-03-3013261325core:PlantMachinery2024-04-012025-03-3013261325core:Vehicles2024-04-012025-03-3013261325core:FurnitureFittings2024-04-012025-03-3013261325core:OfficeEquipment2024-04-012025-03-3013261325core:NetGoodwill2024-04-012025-03-3013261325core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3013261325core:ListedExchangeTraded2024-04-012025-03-3013261325core:UnlistedNon-exchangeTraded2024-04-012025-03-3013261325core:MoreThanFiveYears2024-04-012025-03-3013261325core:Non-currentFinancialInstruments2025-03-3013261325core:Non-currentFinancialInstruments2024-03-3113261325dpl:CostSales2024-04-012025-03-3013261325dpl:DistributionCosts2024-04-012025-03-3013261325core:LandBuildings2024-04-012025-03-3013261325core:PlantMachinery2024-04-012025-03-3013261325core:Vehicles2024-04-012025-03-3013261325core:FurnitureFittings2024-04-012025-03-3013261325core:OfficeEquipment2024-04-012025-03-3013261325dpl:AdministrativeExpenses2024-04-012025-03-3013261325core:NetGoodwill2024-04-012025-03-3013261325core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3013261325dpl:GroupUndertakings2024-04-012025-03-3013261325dpl:ParticipatingInterests2024-04-012025-03-3013261325dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3013261325core:ListedExchangeTraded2024-04-012025-03-3013261325dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3013261325core:UnlistedNon-exchangeTraded2024-04-012025-03-3013261325dpl:CostSales2023-04-012024-03-3113261325dpl:DistributionCosts2023-04-012024-03-3113261325core:LandBuildings2023-04-012024-03-3113261325core:PlantMachinery2023-04-012024-03-3113261325core:Vehicles2023-04-012024-03-3113261325core:FurnitureFittings2023-04-012024-03-3113261325core:OfficeEquipment2023-04-012024-03-3113261325dpl:AdministrativeExpenses2023-04-012024-03-3113261325core:NetGoodwill2023-04-012024-03-3113261325core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113261325dpl:GroupUndertakings2023-04-012024-03-3113261325dpl:ParticipatingInterests2023-04-012024-03-3113261325dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3113261325core:ListedExchangeTraded2023-04-012024-03-3113261325dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3113261325core:UnlistedNon-exchangeTraded2023-04-012024-03-3113261325core:NetGoodwill2025-03-3013261325core:IntangibleAssetsOtherThanGoodwill2025-03-3013261325core:LandBuildings2025-03-3013261325core:PlantMachinery2025-03-3013261325core:Vehicles2025-03-3013261325core:FurnitureFittings2025-03-3013261325core:OfficeEquipment2025-03-3013261325core:AfterOneYear2025-03-3013261325core:WithinOneYear2025-03-3013261325core:ListedExchangeTraded2025-03-3013261325core:UnlistedNon-exchangeTraded2025-03-3013261325core:ShareCapital2025-03-3013261325core:SharePremium2025-03-3013261325core:RevaluationReserve2025-03-3013261325core:OtherReservesSubtotal2025-03-3013261325core:RetainedEarningsAccumulatedLosses2025-03-3013261325core:NetGoodwill2024-03-3113261325core:IntangibleAssetsOtherThanGoodwill2024-03-3113261325core:LandBuildings2024-03-3113261325core:PlantMachinery2024-03-3113261325core:Vehicles2024-03-3113261325core:FurnitureFittings2024-03-3113261325core:OfficeEquipment2024-03-3113261325core:AfterOneYear2024-03-3113261325core:WithinOneYear2024-03-3113261325core:ListedExchangeTraded2024-03-3113261325core:UnlistedNon-exchangeTraded2024-03-3113261325core:ShareCapital2024-03-3113261325core:SharePremium2024-03-3113261325core:RevaluationReserve2024-03-3113261325core:OtherReservesSubtotal2024-03-3113261325core:RetainedEarningsAccumulatedLosses2024-03-3113261325core:NetGoodwill2023-03-3113261325core:IntangibleAssetsOtherThanGoodwill2023-03-3113261325core:LandBuildings2023-03-3113261325core:PlantMachinery2023-03-3113261325core:Vehicles2023-03-3113261325core:FurnitureFittings2023-03-3113261325core:OfficeEquipment2023-03-3113261325core:AfterOneYear2023-03-3113261325core:WithinOneYear2023-03-3113261325core:ListedExchangeTraded2023-03-3113261325core:UnlistedNon-exchangeTraded2023-03-3113261325core:ShareCapital2023-03-3113261325core:SharePremium2023-03-3113261325core:RevaluationReserve2023-03-3113261325core:OtherReservesSubtotal2023-03-3113261325core:RetainedEarningsAccumulatedLosses2023-03-3113261325core:AfterOneYear2024-04-012025-03-3013261325core:WithinOneYear2024-04-012025-03-3013261325core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3013261325core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3013261325core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3013261325core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3013261325core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3013261325core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3013261325core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3013261325core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3013261325core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3013261325core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3013261325core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3013261325core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3013261325core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3013261325core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3013261325core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3013261325core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3013261325core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3013261325core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3013261325core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3113261325core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3113261325core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3113261325core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3113261325core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3113261325core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3113261325core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3113261325core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3113261325core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3113261325bus:Director12024-04-012025-03-3013261325core:FurnitureFittingsToolsEquipment2024-03-3113261325core:FurnitureFittingsToolsEquipment2024-04-012025-03-3013261325core:FurnitureFittingsToolsEquipment2025-03-30

THE KLINIK AESTHETIC LTD

Registered Number
13261325
(England and Wales)

Unaudited Financial Statements for the Period ended
30 March 2025

THE KLINIK AESTHETIC LTD
Company Information
for the period from 1 April 2024 to 30 March 2025

Director

WATSON, Faye Louise

Registered Address

4 High Street
Bishop's Stortford
CM23 2LT

Registered Number

13261325 (England and Wales)
THE KLINIK AESTHETIC LTD
Balance Sheet as at
30 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets324,74419,446
24,74419,446
Current assets
Stocks43,5242,015
Debtors538,89523,547
Cash at bank and on hand2,40611,327
44,82536,889
Creditors amounts falling due within one year6(68,847)(56,491)
Net current assets (liabilities)(24,022)(19,602)
Total assets less current liabilities722(156)
Net assets722(156)
Capital and reserves
Called up share capital11
Profit and loss account721(157)
Shareholders' funds722(156)
The financial statements were approved and authorised for issue by the Director on 1 August 2025, and are signed on its behalf by:
WATSON, Faye Louise
Director
Registered Company No. 13261325
THE KLINIK AESTHETIC LTD
Notes to the Financial Statements
for the period ended 30 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Current taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current or deferred taxation assets and liabilities are not discounted. Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Tangible fixed assets and depreciation
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Reducing balance (%)Straight line (years)
Plant and machinery15-
Fixtures and fittings15-
Office Equipment-3
Stocks and work in progress
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell.
2.Average number of employees

20252024
Average number of employees during the year11
3.Tangible fixed assets

Plant & machinery

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 April 2426,8581,2261,73829,822
Additions7,2482,526-9,774
At 30 March 2534,1063,7521,73839,596
Depreciation and impairment
At 01 April 249,35934167610,376
Charge for year3,3905125744,476
At 30 March 2512,7498531,25014,852
Net book value
At 30 March 2521,3572,89948824,744
At 31 March 2417,4998851,06219,446
4.Stocks

2025

2024

££
Finished goods3,5242,015
Total3,5242,015
5.Debtors: amounts due within one year

2025

2024

££
Other debtors35,52019,722
Prepayments and accrued income3,3753,825
Total38,89523,547
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables1,248-
Taxation and social security14,895-
Other creditors51,50755,368
Accrued liabilities and deferred income1,1971,123
Total68,84756,491
7.Directors advances, credits and guarantees
Included in creditors: amounts falling due within one year were loans from the director of £45,530 (2024: £50,556). The loans were interest free, with no fixed date for repayment.